リバロキサバンの薬理動力学と臨床結果に対する遺伝子ポリモルフィズムの影響: 最新技術レビュー
Ling Wang1,2, Guoquan Chen2, Wei Hu3
1School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, People's Republic of China.
Drug design, development and therapy
|September 2, 2025
まとめ
直接投与される抗凝固剤であるリバロキサバンに対する患者の反応には遺伝的変異が影響する. このレビューは,リバロキサバンの薬理学に関する12の研究をまとめ,25の遺伝子ポリモルフィックサイトを特定しましたが,現在の証拠は,研究異質性によって制限されています.
科学分野:
- 薬剤遺伝学
- 臨床薬理学
- ゲノミクス
背景:
- リバロキサバンは直接投与される血液凝固抑制剤 (DOAC) で,XA因子を抑制する.
- リバロキサバは一般的に予測可能ですが,患者の反応において個体間での有意な変動を示しています.
- 遺伝的要因は,この多様性に寄与する要因としてますます認識されています.
研究 の 目的:
- リバロキサバンに関する既存の薬理学的研究をレビューし,要約する.
- リバロキサバンの変異性に関連した報告された遺伝子ポリモルフィックサイトを特定し,リストアップする.
- 既存の証拠の影響と限界を評価する.
主な方法:
- リバロキサバンに関する12件の薬剤遺伝学的研究の体系的レビュー
- 複数の遺伝子 (例えば,ABCB1,ABCG2,CYP3A4) で報告された25の遺伝子ポリモルフサイトをまとめました.
- 研究の異質性と結果の一貫性の分析
主要な成果:
- リバロキサバンに関連する12の薬理学研究と25の遺伝子ポリモルフィックサイトを要約した.
- ABCB1,ABCG2,CYP3A4,CYP3A5,CYP2J2,CYP2J19,ABCA6およびAKR7A3を含む主要な遺伝子が特定されました.
- 既存の研究で有意な異質性と不一致性が見つかりました.
結論:
- リバロキサバンの遺伝子ポリモルフィズムに関する現在の証拠は,研究異質性のために臨床効果が限られている.
- 大規模で,グローバルで,複数のセンターでの臨床試験が検証に必要である.
- 将来の研究は,臨床試験のための潜在的な遺伝子ロケーションの検証に焦点を当てるべきです.
関連する概念動画
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
112
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
112
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
293
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
293
01:09Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
226
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
226
01:21Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
312
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
312
01:19Factors Affecting Drug Biotransformation: Biological
231
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
231